Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 5/2024

21-03-2024 | Chronic Lymphocytic Leukemia | Correspondence

Effective treatment of pleural effusion in chronic lymphocytic leukemia with acalabrutinib: a case report

Authors: Shuhei Kurosawa, Takako Yokota, Yusuke Takada, So Okubo, Moe Masuda, Hitomi Nakayama, Aki Sakurai, Chisako Ito, Yoshinobu Aisa, Tomonori Nakazato

Published in: Annals of Hematology | Issue 5/2024

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Woyach JA, Ruppert AS, Heerema NA et al (2018) Ibrutinib regimens versus chemoimmunotherapy in older patients with untreated CLL. N Engl J Med 379:2517–2528CrossRefPubMedPubMedCentral
2.
3.
Byrd JC, Hillmen P, Ghia P et al (2021) Acalabrutinib versus ibrutinib in previously treated chronic lymphocytic leukemia: Results of the first randomized phase III trial. J Clin Oncol 39:3441–3452CrossRefPubMedPubMedCentral
4.
Cheng L, Huang M, Wei J, Xu H, Zhou M, Jiang L (2022) Complete resolution of chylothorax with ibrutinib in chronic lymphocytic leukemia: a case report. Ann Palliat Med 11:1833–1837CrossRefPubMed
5.
Ebinama U, Wilson NR, Ghosh A, George BS (2022) Therapeutic management of chronic lymphocytic leukemia presenting with recurrent massive ascites. Curr Oncol 29:6787–6793CrossRefPubMedPubMedCentral
6.
Gustine JN, Meid K, Hunter ZR, Xu L, Treon SP, Castillo JJ (2018) MYD88 mutations can be used to identify malignant pleural effusions in Waldenstrom macroglobulinaemia. Br J Haematol 180:578–581CrossRefPubMed
7.
Barnes M, Sharma P, Kumar V, Kaell A, LiPera W (2020) Pleural fluid MYD88 L265P mutation supporting diagnosis and decision to treat extramedullary Waldenstrom’s macroglobulinemia: a case report. J Med Case Rep 14:98CrossRefPubMedPubMedCentral
8.
Rogers M, Iyengar S, Wotherspoon A, Dearden C (2015) Extramedullary haematopoiesis in chronic lymphocytic leukaemia. Br J Haematol 171:442CrossRefPubMed
9.
Ratterman M, Kruczek K, Sulo S, Shanafelt TD, Kay NE, Nabhan C (2014) Extramedullary chronic lymphocytic leukemia: systematic analysis of cases reported between 1975 and 2012. Leuk Res 38:299–303CrossRefPubMed
10.
Alexandrakis MG, Passam FH, Kyriakou DS, Bouros D (2004) Pleural effusions in hematologic malignancies. Chest 125:1546–1555CrossRefPubMed
Metadata
Title
Effective treatment of pleural effusion in chronic lymphocytic leukemia with acalabrutinib: a case report
Authors
Shuhei Kurosawa
Takako Yokota
Yusuke Takada
So Okubo
Moe Masuda
Hitomi Nakayama
Aki Sakurai
Chisako Ito
Yoshinobu Aisa
Tomonori Nakazato
Publication date
21-03-2024
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 5/2024
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-024-05721-z

Other articles of this Issue 5/2024

Annals of Hematology 5/2024 Go to the issue

Original Article

Development of a whole spinal MRI-based tumor burden scoring method in participants with multiple myeloma: a pilot study of prognostic significance

Correction

Correction to: Sutimlimab improves quality of life in patients with cold agglutinin disease: results of patientreported outcomes from the CARDINAL study

Correspondence

Very long-term efficacy of venetoclax combined with hypomethylating agents in two AML elderly: is it the time for treatment discontinuation strategies?

Letter to the Editor

Loeys-Dietz syndrome with concomitant aplastic anemia

Original Article

Spotlight on the real-world treatment of CML pts in Germany: a retrospective survey in private oncology practices

Original Article

Cause-specific mortality in a population-level cohort of diffuse large B-cell lymphoma following chemotherapy in the early 21st century
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits